Post-IPO Equity - Karyopharm Therapeutics - Mar 6, 2020 Funding Round Profile - Cointime

Bitcoin $79,950.30 +4.47%
Ethereum $3,228.16 +5.66%
BNB $643.25 +2.88%
Optimism $1.70 +2.94%
Arbitrum $0.65 +5.59%
Solana $207.02 +2.49%
Polygon $0.41 +5.44%
Cosmos $5.29 +11.10%
Avalanche $32.10 +8.87%

Bitcoin $79,950.30 +4.47%
Ethereum $3,228.16 +5.66%
BNB $643.25 +2.88%
Optimism $1.70 +2.94%
Arbitrum $0.65 +5.59%
Solana $207.02 +2.49%
Polygon $0.41 +5.44%
Cosmos $5.29 +11.10%
Avalanche $32.10 +8.87%

Karyopharm Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 172.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Jun 30, 2014	Post-IPO Equity	$ 111M		Detail
Jul 31, 2013	Series B	$ 19M	Delphi Ventures,Foresite Capital,etc.	Detail
May 20, 2013	Series B	$ 48.20M	Delphi Ventures	Detail
Nov 3, 2010	Series A	$ 20M		Detail
Jan 6, 2011	Grant	$ 1M	Multiple Myeloma Research Foundation	Detail
Nov 2, 2011	Series A	$ 10M	Chione	Detail
Nov 6, 2013	IPO	$ 108.80M		Detail